Spontaneous hemoperitoneum in pregnancy: Italian prospective population-based cohort study.


Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
11 2022
Historique:
revised: 17 06 2022
received: 08 04 2022
accepted: 16 07 2022
pubmed: 2 9 2022
medline: 22 10 2022
entrez: 1 9 2022
Statut: ppublish

Résumé

Spontaneous hemoperitoneum in pregnancy is defined as a sudden non-traumatic intraperitoneal bleeding in pregnancy and up to 42 days postpartum. In the present study we aim to estimate the incidence and investigate the risk factors, the management and the outcomes of spontaneous hemoperitoneum in pregnancy in order to improve its clinical identification and reduce avoidable maternal deaths. This is a prospective population-based cohort study, set in maternity units from nine Italian regions covering 75% of the national births. The study population comprises all women admitted for spontaneous intraperitoneal hemorrhage during pregnancy and up to 42 days postpartum between November 2017 and March 2020. Incident cases were reported by trained clinicians through electronic data collection forms. Descriptive statistics were performed. The main outcome measures included incidence rate of spontaneous hemoperitoneum in pregnancy, association with potential risk factors, clinical management and maternal and perinatal outcomes. Twenty-nine cases met the adopted definition of spontaneous hemoperitoneum in pregnancy with an estimated incidence rate of 0.04 per 1000 births. An increased risk ratio (RR) of this condition was observed in pregnancies conceived by assisted reproductive technology (RR = 6.60, 95% CI 2.52-17.29), in the case of multiple pregnancies (RR = 6.57, 95% CI 1.99-21.69) and maternal age ≥35 years (RR 2.10, 95% CI 1.01-4.35). In 17/29 cases the bleeding site was intra-pelvic (23.5% in the posterior uterine wall and 35.2% in the left hemipelvis). Laparotomy represented the surgical treatment in 27 cases (93%), and most women underwent a cesarean delivery (92.6%). Median blood loss was 1900 mL, one hysterectomy was necessary, and two women died. Twenty-two preterm births were recorded. Spontaneous hemoperitoneum in pregnancy is a rare, life-threatening condition associated with high perinatal morbidity and mortality. Maternal age ≥35 years, multiple pregnancies and assisted reproductive technology were associated to a higher risk of the condition. Two women of 29 died and 70% of births occurred preterm.

Identifiants

pubmed: 36047477
doi: 10.1111/aogs.14431
pmc: PMC9812087
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1220-1226

Informations de copyright

© 2022 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Références

Ann Ist Super Sanita. 2019 Oct-Dec;55(4):363-370
pubmed: 31850864
BJOG. 2019 Feb;126(3):394-401
pubmed: 28755459
Acta Obstet Gynecol Scand. 2018 Nov;97(11):1317-1324
pubmed: 29956300
BJOG. 2017 Jan;124(2):306-312
pubmed: 27704657
Obstet Gynecol. 2003 Jan;101(1):164-6
pubmed: 12517662
Eur J Obstet Gynecol Reprod Biol. 2017 Dec;219:57-65
pubmed: 29054042
Best Pract Res Clin Obstet Gynaecol. 2009 Jun;23(3):287-96
pubmed: 19303368
Fertil Steril. 2009 Oct;92(4):1243-1245
pubmed: 19439293
Eur Radiol. 2013 Dec;23(12):3485-500
pubmed: 23990045
J Obstet Gynaecol Res. 2021 Aug;47(8):2646-2652
pubmed: 33949042
Acta Obstet Gynecol Scand. 2022 Nov;101(11):1220-1226
pubmed: 36047477
Hum Reprod. 2014 Nov;29(11):2393-401
pubmed: 25205752
Fertil Steril. 2016 Sep 1;106(3):692-703
pubmed: 27336207
PLoS One. 2016 Apr 21;11(4):e0154227
pubmed: 27101396

Auteurs

Martina Ilaria Mazzocco (MI)

Obstetrics and Gynecology, Hospital Vittore Buzzi, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Serena Donati (S)

National Center for Disease Prevention and Health Promotion, Istituto Superiore di Sanità - Italian National Institute of Health, Rome, Italy.

Alice Maraschini (A)

Technical-scientific statistical service, Italian National Institute of Health, Rome, Italy.

Edoardo Corsi (E)

National Center for Disease Prevention and Health Promotion, Istituto Superiore di Sanità - Italian National Institute of Health, Rome, Italy.
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Elisabetta Colciago (E)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Fabiola Guelfi (F)

Obstetrics and Gynecology, Hospital Vittore Buzzi, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Irene Cetin (I)

Obstetrics and Gynecology, Hospital Vittore Buzzi, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH